documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

4 rows where docket_id = "FDA-2019-D-1536" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_month, open_for_comment, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

posted_year 2

document_type 2

agency_id 1

id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2019-D-1536-0037 FDA Opioid Analgesic Drugs: Considerations for Benefit-Risk Assessment Framework; Draft Guidance for Industry; Availability FDA-2019-D-1536 Opioid Analgesic Drugs: Considerations for Benefit-Risk Assessment Framework Guidance for Industry; Draft Guidance Other Guidance 2026-05-13T04:00:00Z 2026 5 2026-05-13T04:00:00Z   2026-05-13T15:23:30Z   1 0 09000064b92d0c28
FDA-2019-D-1536-0014 FDA Opioid Analgesic Drugs: Considerations for Benefit-Risk Assessment Framework; Draft Guidance for Industry; Availability FDA-2019-D-1536 Request for Extension from Pharmaceutical Research and Manufacturers of America (PhRMA) Other Request for Extension 2019-07-15T04:00:00Z 2019 7 2019-07-15T04:00:00Z   2019-07-15T16:20:56Z   0 0 0900006483d7cb9c
FDA-2019-D-1536-0001 FDA Opioid Analgesic Drugs: Considerations for Benefit-Risk Assessment Framework; Draft Guidance for Industry; Availability FDA-2019-D-1536 Opioid Analgesic Drugs: Considerations for Benefit-Risk Assessment Framework; Draft Guidance for Industry; Availability Notice Notice of Availability 2019-06-21T04:00:00Z 2019 6 2019-06-21T04:00:00Z 2019-08-21T03:59:59Z 2019-08-22T01:05:17Z 2019-13221 0 0 0900006483d2f6be
FDA-2019-D-1536-0002 FDA Opioid Analgesic Drugs: Considerations for Benefit-Risk Assessment Framework; Draft Guidance for Industry; Availability FDA-2019-D-1536 Opioid Analgesic Drugs: Considerations for Benefit- Risk Assessment Framework; Guidance for Industry; Draft Guidance Other Guidance 2019-06-20T04:00:00Z 2019 6 2019-06-20T04:00:00Z   2024-11-12T23:02:42Z   1 0 0900006483d481b3

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;